Lithotripsy is a process used to break stones of the kidney and other organs such as the gall bladder, liver and urethra through a ultrasound shock wave. Kidney stones occur when substances like urine crystallize in stones or solid mass forming the kidneys and thus prevent the urine from passing through your body. This can lead to bleeding, severe urinary pain, infection and kidney damage. The development of these stones can result. The kidney stones in urine and the bladder are the most common causes of blood. Extracorporeal shock wave lithotripsy (ESWL) is one of the most frequently reported lithotripsy outside the body and refers to treatment of shock waves. The ESWL produces high-energy shock waves like sound waves, x-rays or ultrasound that pass through the body until they do not strike the kidney stones. ESWL is a non-invasive procedure that requires no open procedure. This procedure is usually safe and takes only 45 minutes. Laser lithotripsis is also used to remove stones from the kidney, ureter and bladder, it is an operation and takes time to perform the operation.
The report provides analysis of global Lithotripsy Device market for the period 2016-2026, wherein 2019 to 2026 is the forecast period and 2017 is considered as the base year. According to Acumen Research and Consulting, the global Lithotripsy Device market is expected to grow at noteworthy CAGR around 3.6 % throughout the forecast period and reach around US$ 950 million by 2026.
In the forecast period, the increasing prevalence of kidney stones is the key factor to drive the development of the lithotripsy device market. Lithotripsis has become the most popular treatment method for kidney stones over the years. This was due in large part to its relative safety, low costs, reduced recovery time and positive patient results. In addition, all kidney stone composites can be treated with intracorporeal lithotrypsy devices with great success rates without any significant complications for the ureteral stones. Lack of innovation and the interest of industry to finance younger technology, on the other hand, are the main factors limiting the growth of Lithotripsy device global market.
The effects of modernized farming continue to be reflected in the epidemic of obesity in different regions worldwide. The obesity rate rose from around 15% in the 1980s to about 35% in the 21st century. Based on different research papers on kidney stones, the prevalence of kidney stones in the world has increased. One of the main factors that increases the prevalence rate of kidney stones is supposed to be changing the life style. The increasing number of kidney stone cases also contributed to decreased fluid and calcium consumption. Different epidemiological trials have also shown that increased intake of sodium and animal protein increases the risk of kidney stone. Therefore the growth of the Lithotripsy market is predicated to be driven by an increasing prevalence of kidney stones.
In addition, the world market for lithotrypsy devices is expected to increase favorable reimbursement for lithotripsy and awareness of kidney health. In addition, the market throughout the world is likely to be propelled towards minimally invasive procedures. In addition, high costs for extracorporeal lithotripsis and the alternative treatment available are important factors that are expected to limit market conditions. Approximate 10 percent of the world's population is affected by chronic renal diseases, according to the National Kidney Foundation. The Eastern Mediterranean Health Journal states that children and adults have high prevalence of upper urinary tract stones.
As far as the product is concerned, the extracorporeal lithotrips segment represented the world market leader in 2017, and the trend is expected to continue over the period of forecast. The prevalence of pancreas, biliary and ureteral stones throughout the world is projected to improve during the forecast period. This will increase the segment. A higher demand for lithotripsy equipment is expected to drive the market during the forecast period due to a tendency towards minimally invasive procedures.
The global lithotripsy market will increase during the forecast period as emerging technologies in lithotripsy are projected. Mosses technology is a new laser lithotripsy technique that is used to separate water from stone and laser tip. Lumenis, Moses Holmium is a faser-Holmium laser combination that is used for the processing of stones in places that are hard to reach. The dusting technique is used to remove stones, while the pop dusting technique is used to remove several pieces of stone. Laser thulium is a new laser lithotripsy technology. Smaller fibres, more rock removal and greater flexibility include its advantages. RevoLix DUO is offered by LISA Laser Products GmbH as a combination of holmium and Thulium laser for the urological application of lithotrypsy.
The report provides detailed product-and application segmentation of the global market for lithotripsis devices. The market is divided into regions (North America, Europe, Asia Pacific, Latin America and Middle East and Africa). The global market for lithotripsy devices is likely to be driven by favorable repayment policies and increased prevalence of kidney stones.
Regions are divided into North America, Europe, Asia Pacific, Latin America and the Middle East & Africa, the world market for lithotripsy devices. The major share of the global market in 2017 was North America. The presence of key players and the high rate of technological adoption in the region drive the market of North America. In addition, an increase in kidney stone disease prevalence is likely to boost the region's market. In 2015, 10 to 25% of adults had gallbladder stones, according to the article published in the Cleveland Clinic Journal of Medicine. Routine stones in the United States are diagnosed once in their lives by about 13 percent of men and 7 percent of women. The European market is driven by an increase in kidney stone prevalence. About 1% to 2% of people in Germany suffer each year from renal stones. Asia Pacific's market has grown as gallstones and kidney stones in the region are becoming more prevalent.
Lithotripsy Device Market by Product
Lithotripsy Device Market by Application
Global Lithotripsy Device Market, by Geography
The market research study on “Lithotripsy Device Market (By Product: Extracorporeal Lithotripsy, Intracorporeal Lithotripsy; By Application: Kidney Stones Biliary Duct Stones, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Lithotripsy Device market segments with market dynamics and their impact. The report provides insights on global Lithotripsy Device market by equipment, by application, and major geographic regions. The report also covers basic technology development policies.
The report offers an overview of the market and statistical diagrams to support the expected figures. Our analysts predict the market scope and future prospects in an insightful way. The Acumen Research and Consulting report contains a comprehensive analysis of the global market in Lithotripsy Device segmented by molecular type, test type and region. The report outlines numerous growth strategies implemented by companies as well as the latest market trends. The market share and current position of all leading players are discussed in detail. It analyzes players ' new revenue sources and highlights the different strategies.
Key Players and Strategies
The report also provides profiles of the world's leading players in the lithotripsy device sector. These include: EDAP TMS, Siemens Healthcare GmbH, Dornier MedTech, Cook, Karl STORZ, Richard Wolf GmbH, & SMS; and BostonScientific Corporating; Olympus Corporation, C. R. Bard, Inc. The launch of new products is expected to drive the global market during the forecast period, and the focus is on the development of technologally advanced products by companies and product approvals. Dornier MedTech started in May 2018 with a new lithotripter system Dornier Delta III and SmartLitho. Dornier MedTech was approved for the Delta III product in Japan by the Pharmaceutical and Medical Devices Agency in July 2018. In April 2018, Cybersonics, Inc. was purchased by Olympus Corporation to design and manufacture lithotripsy systems.